It calls for clarity and certainty as early as possible to enable our industry to make the necessary changes and to transition smoothly into the new framework.
Co-signatories to the statement include: PAGB, Association of the British Pharmaceutical Industry (ABPI), The Association of the European Self-Medication Industry (AESGP); The European Federation of Pharmaceutical Industries and Associations (EFPIA); EUCOPE; EuropaBio; Medicines for Europe; British Generic Manufacturers Association (BGMA); and the BioIndustry Association (BIA).
PAGB’s participation reflects our view that the consumer healthcare industry faces many of the same challenges being articulated by our colleagues in the prescription pharmaceutical medicines, medical devices and food sectors. PAGB is working closely with colleagues in the trade associations for those industries and is supportive of issues raised by those sectors
PAGB supports the points made in the letter, which largely reflect PAGB’s EU Exit position
